Caleph B. Wilson
25 works · 780 citations · h-index 8
Top works
- Multifactorial T-cell Hypofunction That Is Reversible Can Limit the Efficacy of Chimeric Antigen Receptor–Transduced Human T cells in Solid Tumors
- Macrophage-Stimulating Protein, the Ligand for the Stem Cell-Derived Tyrosine Kinase/RON Receptor Tyrosine Kinase, Inhibits IL-12 Production by Primary Peritoneal Macrophages Stimulated with IFN-γ and Lipopolysaccharide
- Cultured blood dendritic cells retain HIV-1 antigen-presenting capacity for memory CTL during progressive HIV-1 infection
- Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality
- TCR affinity and specificity requirements for human regulatory T-cell function
- Inhibition of TLR4-Induced IκB Kinase Activity by the RON Receptor Tyrosine Kinase and Its Ligand, Macrophage-Stimulating Protein
- The RON Receptor Tyrosine Kinase Regulates IFN-γ Production and Responses in Innate Immunity
- In vitro Modulation of Cytokine Expression by Enkephalin-Derived Peptides
- Loss of Programmed Death Ligand-1 Expression on Donor T Cells Lessens Acute Graft-Versus-Host Disease Lethality
- High-affinity TCRs confer antigen sensitivity in HIV gag-specific effector CD8 T cells (VAC7P.991)
- The inflammatory control valve: Modulation of responses to LPS and IFN-gamma by the RON receptor tyrosine kinase in vitro and in vivo
- Supplementary Table 1 from Multifactorial T-cell Hypofunction That Is Reversible Can Limit the Efficacy of Chimeric Antigen Receptor–Transduced Human T cells in Solid Tumors
- Supplementary Figures 1 - 5 from Multifactorial T-cell Hypofunction That Is Reversible Can Limit the Efficacy of Chimeric Antigen Receptor–Transduced Human T cells in Solid Tumors
- Supplementary Figures 1 - 5 from Multifactorial T-cell Hypofunction That Is Reversible Can Limit the Efficacy of Chimeric Antigen Receptor–Transduced Human T cells in Solid Tumors
- Supplementary Methods from Multifactorial T-cell Hypofunction That Is Reversible Can Limit the Efficacy of Chimeric Antigen Receptor–Transduced Human T cells in Solid Tumors
- Data from Multifactorial T-cell Hypofunction That Is Reversible Can Limit the Efficacy of Chimeric Antigen Receptor–Transduced Human T cells in Solid Tumors
- A Preclinical Model Tto Study Tumor-Infiltrating Lymphocyte (TIL) Anergy/Exhaustion In Adoptive T Cell Therapy (ACT) Of Thoracic Malignancies
- Acknowledgement to the Reviewers
- Regulation of TLR4 signaling in macrophages by Macrophage Stimulating Protein, the ligand for the Ron receptor tyrosine kinase (134.20)
- Supplementary Table 2 from Multifactorial T-cell Hypofunction That Is Reversible Can Limit the Efficacy of Chimeric Antigen Receptor–Transduced Human T cells in Solid Tumors